Cedric Francois - 16 Jan 2024 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role: Chief Executive Officer, Director
Signature: /s/ David Watson, attorney-in-fact for Cedric Francois
Issuer symbol: APLS
Transactions as of: 16 Jan 2024
Net transactions value: +$6,425,980
Form type: 4
Filing time: 17 Jan 2024, 16:32:17 UTC
Previous filing: 21 Nov 2023
Next filing: 23 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APLS	Common Stock	Award	$0	+72,094	+27%	$0.000000	341,749	16 Jan 2024	Direct	F1
transaction	APLS	Common Stock	Sale	$524,514	-7,851	-2.3%	$66.81	333,898	16 Jan 2024	Direct	F2
holding	APLS	Common Stock						382,946	16 Jan 2024	Indirect Owner (The Cedric Francois Irrevocable Trust of 2023 - 2)	F3
holding	APLS	Common Stock						804,211	16 Jan 2024	Indirect Owner (The Cedric Francois Irrevocable Trust of 2023)	F4
holding	APLS	Common Stock						300,000	16 Jan 2024	Indirect Owner (The Francois Grossi Trust)	F5
holding	APLS	Common Stock						234,411	16 Jan 2024	Indirect Owner (The Francois-DuBois Educational Trust)	F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APLS	Stock Option (Right to Buy)	Award	$6,950,494	+104,834		$66.30	104,834	16 Jan 2024	Common Stock	104,834	$66.30	Direct	F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This represents an award of Restricted Stock Units granted 01/16/2024 that vests annually from grant date over a four year period subject to continued service.
F2	This represents shares sold to cover tax withholding on the Restricted Stock Units released on 01/12/2024.
F3	The securities are held by The Cedric Francois Irrevocable Trust of 2023 - 2. William V. A. Zorn is the trustee of The Cedric Francois Irrevocable Trust of 2023 - 2. The reporting person disclaims beneficial ownership over the shares held by The Cedric Francois Irrevocable Trust of 2023 - 2 except to the extent of his pecuniary interest therein.
F4	The securities are held by The Cedric Francois Irrevocable Trust of 2023. William V. A. Zorn is the trustee of The Cedric Francois Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Cedric Francois Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
F5	The securities are held by The Francois Grossi Trust, for which Juliana Grossi, the spouse of the reporting person, serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Francois Grossi Trust except to the extent of his pecuniary interest therein.
F6	The securities are held by The Francois-DuBois Educational Trust, for which the Fiduciary Trust Company of New England serves as trustee. The reporting person disclaims beneficial ownership over the shares held by The Francois-DuBois Educational Trust except to the extent of his pecuniary interest therein.
F7	This represents a stock option award granted 01/16/2024 that vests over a four year period. 25% vests one year from grant date and the remaining 75% vests monthly thereafter subject to continued service.